John M. Sprague
CIK: 0001730056
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
T2 Biosystems, Inc.
Discretionary Trading P&L
Holdings
John M. Sprague files insider reports with the SEC as CFO of T2 Biosystems, Inc. (TTOO). Signal8 holds 2 reported Form 4/5 transactions by John M. Sprague since Sep 2024. The most recent reported transaction is a grant / award (Form 4 code A) in TTOO, dated Nov 4, 2024.
About Sprague John M
Sprague John M (SEC CIK 0001730056) files insider reports with the SEC as CFO of T2 Biosystems, Inc. (TTOO).
Signal8 holds 1 ownership filing by Sprague John M, a Form 4, filed on Jan 2, 2025. Those filings report 2 transactions, the latest on Nov 4, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Sprague John M's filings is in LEXINGTON, MA.
Recent filings by Sprague John M
- Nov 4, 2024: Grants or awards of TTOO derivative securities (2 lines, Form 4, code A).
Other insiders filing for T2 Biosystems, Inc. (TTOO)
- LIEBMAN SEYMOUR, Director
- Giffin Brett A., Chief Commercial Officer
- Adams Laura Lee, Director
- CUMMING JOHN W, Director
- Gibbs Michael Terrence, General Counsel
- Saunders Ninfa, Director